Form 4 Tracker
Kiniksa Pharmaceuticals International, plc
KNSA

27 insider filings · Latest: Jun 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 1, 2026May 5 4:54 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Sale
58,424$53.71$3.1M65,623(D)

View →

May 1, 2026May 1 4:32 PMSanj K PatelDirector, CHAIRMAN & CEO
Sale
48,565$54.02$2.6M0(D)

View →

Apr 30, 2026Apr 30 6:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Sale
2,141$54.01$115.6K0(D)

View →

Apr 29, 2026Apr 30 6:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Sale
22,544$54.01$1.2M0(D)

View →

Apr 28, 2026Apr 30 6:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Sale
483,654$51.86$25.1M0(D)

View →

Apr 28, 2026Apr 29 4:46 PMBarry D QuartDirector
Sale
13,099$50.10$656.3K12,546(D)

View →

Apr 9, 2026Apr 13 4:35 PMMichael R MegnaCHIEF ACCOUNTING OFFICER
Sale
6,625$46.69$309.3K27,418(D)

View →

Apr 9, 2026Apr 13 4:34 PMRoss MoatCHIEF OPERATING OFFICER
Sale
1,703$46.69$79.5K12,029(D)

View →

Apr 6, 2026Apr 8 4:43 PMSanj K PatelDirector, CHAIRMAN & CEO
Sale
7,278$50.01$364.0K0(D)

View →

Apr 6, 2026Apr 8 4:39 PMRoss MoatCHIEF OPERATING OFFICER
Sale
2,367$48.58$115.0K12,029(D)

View →

Apr 6, 2026Apr 8 4:34 PMBarry D QuartDirector
Sale
6,901$50.00$345.1K12,546(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 7, 2026Apr 8 4:45 PMEben TessariCHIEF STRATEGY OFFICER
Option Exercise
2,7260(D)

View →

Apr 7, 2026Apr 8 4:44 PMMark RagosaCHIEF FINANCIAL OFFICER
Option Exercise
2,6940(D)

View →

Apr 7, 2026Apr 8 4:43 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
9,9910(D)

View →

Apr 6, 2026Apr 8 4:43 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
7,278$10.36431,904(D)

View →

Apr 7, 2026Apr 8 4:41 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Option Exercise
2,4970(D)

View →

Apr 7, 2026Apr 8 4:39 PMRoss MoatCHIEF OPERATING OFFICER
Option Exercise
2,4770(D)

View →

Apr 7, 2026Apr 8 4:38 PMMichael R MegnaCHIEF ACCOUNTING OFFICER
Option Exercise
3,9320(D)

View →

Apr 6, 2026Apr 8 4:34 PMBarry D QuartDirector
Option Exercise
6,901$14.3326,336(D)

View →

Apr 1, 2026Apr 3 4:41 PMEben TessariCHIEF STRATEGY OFFICER
Grant/Award
58,100$48.1316,600(D)

View →

Apr 1, 2026Apr 3 4:41 PMEben TessariCHIEF STRATEGY OFFICER
Option Exercise
5,9757,371(D)

View →

Apr 1, 2026Apr 3 4:40 PMMark RagosaCHIEF FINANCIAL OFFICER
Grant/Award
54,550$48.1315,600(D)

View →

Apr 1, 2026Apr 3 4:40 PMMark RagosaCHIEF FINANCIAL OFFICER
Option Exercise
5,1875,536(D)

View →

Apr 1, 2026Apr 3 4:39 PMSanj K PatelDirector, CHAIRMAN & CEO
Grant/Award
210,300$48.1360,100(D)

View →

Apr 1, 2026Apr 3 4:39 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
21,32725,826(D)

View →

Apr 1, 2026Apr 3 4:37 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Grant/Award
46,850$48.1313,400(D)

View →

Apr 1, 2026Apr 3 4:37 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Option Exercise
5,8317,371(D)

View →

Apr 1, 2026Apr 3 4:35 PMRoss MoatCHIEF OPERATING OFFICER
Grant/Award
64,700$48.1318,500(D)

View →

Apr 1, 2026Apr 3 4:35 PMRoss MoatCHIEF OPERATING OFFICER
Option Exercise
5,8087,371(D)

View →

Apr 1, 2026Apr 3 4:34 PMMichael R MegnaCHIEF ACCOUNTING OFFICER
Grant/Award
25,550$48.137,300(D)

View →

Apr 1, 2026Apr 3 4:34 PMMichael R MegnaCHIEF ACCOUNTING OFFICER
Option Exercise
7,5647,931(D)

View →

← Previous

Page 2 of 2